Imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial

Salomon Tendler, Mark Dunphy, Matthew Agee, Joseph O'Donoghue, Rania G. Aly, Noura J. Choudhury, Adam Kesner, Assen Kirov, Audrey Mauguen, Marina K. Baine, Heiko Schöder, Wolfgang Weber, Natasha Rekhtman, Serge K. Lyashchenko, Lisa Bodei, Michael J. Morris, Jason S Lewis, Charles M. Rudin, John T. Poirier